Clinically, human ILC2s were suppressed in liver cirrhosis patients, as evidenced by decreased Areg expression by the ILC2s in human peripheral blood mononuclear cells from liver cirrhosis patients, compared to that of healthy donors (Figure 3N,O). This evidence concerns the gene AREG and cirrhosis of liver.